2022_Sep_ConnectinPharma_Easyfairs_Geneva

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a specialty pharmaceutical company that leverages novel formulation technology platforms to develop and commercialise ready-to-use liquid-stable injectables. The company is focused on creating medicines that are easier to use, including its Gvoke® glucagon injection.


Visit Website

Headquarters
Xeris Pharmaceuticals, Inc
180 North LaSalle Street
Suite 1600
Chicago
IL 60601
United States

Phone / Contact

T: +1 844 445 5704

Connect

Xeris Pharmaceuticals is a specialty pharmaceutical company that leverages novel formulation technology platforms to develop and commercialise ready-to-use liquid-stable injectables. The company is focused on creating medicines that are easier to use, including its Gvoke® glucagon injection, which uses Xeris’s technology to deliver ready-to-use solutions for patients and caregivers alike.

Xeris was founded in 2005 and its shares are traded on the NASDAQ Global Select index (NASDAQ GS: XERS).

Articles by Xeris Pharmaceuticals

Top